BPC-157

We are writing and source-checking this section before it goes live. We would rather leave it blank than publish unverified information.

We are writing and source-checking this section before it goes live. We would rather leave it blank than publish unverified information.

In the United States, BPC-157 may be purchased for legitimate in vitro or animal research as a research chemical. Following the FDA's 2023 compounding guidance, it cannot be legally used in compounded human medications in the U.S. Legal status varies significantly by country. Researchers should verify current regulatory requirements with their institution's compliance office before ordering, as the landscape continues to evolve.

BPC-157 and TB-500 (a synthetic fragment of Thymosin Beta-4) are structurally distinct peptides with different proposed mechanisms. BPC-157 is a 15-amino acid gastric peptide derivative; TB-500 is a 43-amino acid fragment. Both are studied in preclinical tissue-repair research, and some animal studies have examined them in combination. They are not the same compound and should not be treated as interchangeable in research protocols.

No randomised controlled trials of BPC-157 in humans have been published in peer-reviewed literature as of May 2026. All documented evidence comes from in vitro cell studies and in vivo animal models, predominantly in rats and mice. Published clinical trials would be necessary before any conclusions about human efficacy, safety, or dosing could be drawn.

A research-grade COA should include HPLC purity at or above 98%, mass spectrometry confirmation of the correct molecular weight, and the name of the testing laboratory. For cell-culture or in vivo work, endotoxin testing results are also important. Peptide Scanner's comparison table shows COA availability for each listed supplier — click through to the supplier listing for documentation details.

Suppliers are ranked by price per milligram. Rankings are not influenced by referral relationships, supplier payments, or promotional arrangements. Where a referral fee exists, it is disclosed on the supplier's listing page. We never charge suppliers for placement or rankings.

Pricing variation reflects differences in synthesis batch size, purity testing standards, shipping origin, supplier overhead, and whether the supplier manufactures in-house or resells. A higher price does not guarantee higher quality, and a lower price does not imply lower quality — COA documentation is a better proxy for research-grade standards than price alone.